Contemporary Conversations in Retinopathy of Prematurity

Videos From Regeneron

Decision Factors in managing patients with ROP

Faruk Orge, MD; and Darius Moshfeghi, MD

ICROP Classification and ROP Treatment Guidelines

Faruk Orge, MD; and Darius Moshfeghi, MD

Additional Considerations for Treating ROP

Faruk Orge, MD; Darius Moshfeghi, MD

About Regeneron

Regeneron is a leading biotechnology company that invents, develops, and commercializes life-transforming medicines for people with serious diseases. Founded and led for nearly 35 years by physician-scientists, Regeneron's unique ability to repeatedly and consistently translate science into medicine has led to numerous FDA-approved treatments and product candidates in development, almost all of which were homegrown in Regeneron's laboratories.

Visit us online: regeneron.com